Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.pcad.2014.10.004 http://scihub22266oqcxt.onion/10.1016/j.pcad.2014.10.004 C4366314!4366314!25459974     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Prog+Cardiovasc+Dis 2015 ; 57 (5): 431-42 Nephropedia Template TP {{tp|p=25459974|t=2015. Treating Coronary Disease and the Impact of Endothelial Dysfunction |pdf=|usr=}}{{25459974}} gab.com Text Treating Coronary Disease and the Impact of Endothelial Dysfunction JO: Prog Cardiovasc Dis http://www.kidney.de/pget.php?&tw=1&pmid=25459974 #FOAvip Ischemic heart disease is the leading cause of morbidity and mortality throughout the world. Many clinical trials have suggested that lifestyle and pharmacologic interventions are effective in attenuating atherosclerotic disease progression and events development. However, an individualized approach with careful consideration to comprehensive vascular health is necessary to perform successful intervention strategies. Endothelial dysfunction plays a pivotal role in the early stage of atherosclerosis and is also associated with plaque progression and occurrence of atherosclerotic complications. The assessment of endothelial function provides us with important information about individual patient risk, progress and vulnerability of disease, and guidance of therapy. Thus, the application of endothelial function assessment might enable clinicians to innovate ideal individualized medicine. In this review, we summarize the current knowledge on the impact of pharmacological therapies for atherosclerotic cardiovascular disease on endothelial dysfunction, and argue for the utility of non-invasive assessment of endothelial function aiming at individualized medicine. Twit Text FOAVip Treating Coronary Disease and the Impact of Endothelial Dysfunction ????Prog Cardiovasc Dis http://www.kidney.de/pget.php?&tw=1&pmid=25459974 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25459974 #FOAvip English Wikipedia <ref>{{Cite pmid|25459974}}</ref> Treating Coronary Disease and the Impact of Endothelial Dysfunction #MMPMID25459974 Matsuzawa Y; Guddeti RR; Kwon TG; Lerman LO; Lerman A Prog Cardiovasc Dis 2015[Mar]; 57 (5): 431-42 PMID25459974show ga Ischemic heart disease is the leading cause of morbidity and mortality throughout the world. Many clinical trials have suggested that lifestyle and pharmacologic interventions are effective in attenuating atherosclerotic disease progression and events development. However, an individualized approach with careful consideration to comprehensive vascular health is necessary to perform successful intervention strategies. Endothelial dysfunction plays a pivotal role in the early stage of atherosclerosis and is also associated with plaque progression and occurrence of atherosclerotic complications. The assessment of endothelial function provides us with important information about individual patient risk, progress and vulnerability of disease, and guidance of therapy. Thus, the application of endothelial function assessment might enable clinicians to innovate ideal individualized medicine. In this review, we summarize the current knowledge on the impact of pharmacological therapies for atherosclerotic cardiovascular disease on endothelial dysfunction, and argue for the utility of non-invasive assessment of endothelial function aiming at individualized medicine. äTreating Coronary Disease and the Impact of Endothelial Dysfunction (epmc).pdf DeepDyve Pubget Overpricing